Clinical features of autosomal recessive polycystic kidney disease in the Japanese population and analysis of splicing in PKHD1 gene for determination of phenotypes
-
Published:2021-09-18
Issue:2
Volume:26
Page:140-153
-
ISSN:1342-1751
-
Container-title:Clinical and Experimental Nephrology
-
language:en
-
Short-container-title:Clin Exp Nephrol
Author:
Ishiko Shinya, Morisada NaoyaORCID, Kondo Atsushi, Nagai Sadayuki, Aoto Yuya, Okada Eri, Rossanti Rini, Sakakibara Nana, Nagano China, Horinouchi Tomoko, Yamamura Tomohiko, Ninchoji Takeshi, Kaito Hiroshi, Hamada Riku, Shima Yuko, Nakanishi Koichi, Matsuo Masafumi, Iijima Kazumoto, Nozu Kandai
Abstract
Abstract
Background
Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in the PKHD1 gene. The clinical spectrum is often more variable than previously considered. We aimed to analyze the clinical features of genetically diagnosed ARPKD in the Japanese population.
Methods
We conducted a genetic analysis of patients with clinically diagnosed or suspected ARPKD in Japan. Moreover, we performed a minigene assay to elucidate the mechanisms that could affect phenotypes.
Results
PKHD1 pathogenic variants were identified in 32 patients (0–46 years). Approximately one-third of the patients showed prenatal anomalies, and five patients died within one year after birth. Other manifestations were detected as follows: chronic kidney disease stages 1–2 in 15/26 (57.7%), Caroli disease in 9/32 (28.1%), hepatic fibrosis in 7/32 (21.9%), systemic hypertension in 13/27 (48.1%), and congenital hypothyroidism in 3 patients. There have been reported that truncating mutations in both alleles led to severe phenotypes with perinatal demise. However, one patient without a missense mutation survived the neonatal period. In the minigene assay, c.2713C > T (p.Gln905Ter) and c.6808 + 1G > A expressed a transcript that skipped exon 25 (123 bp) and exon 41 (126 bp), resulting in an in-frame mutation, which might have contributed to the milder phenotype. Missense mutations in cases of neonatal demise did not show splicing abnormalities.
Conclusion
Clinical manifestations ranged from cases of neonatal demise to those diagnosed in adulthood. The minigene assay results indicate the importance of functional analysis, and call into question the fundamental belief that at least one non-truncating mutation is necessary for perinatal survival.
Funder
health labor sciences research grant japan society for the promotion of science
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference22 articles.
1. Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet. 2002;30(3):259–69. https://doi.org/10.1038/ng833. 2. Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet. 2002;70(5):1305–17. https://doi.org/10.1086/340448. 3. Follit JA, Li L, Vucica Y, Pazour GJ. The cytoplasmic tail of fibrocystin contains a ciliary targeting sequence. J Cell Biol. 2010;188(1):21–8. https://doi.org/10.1083/jcb.200910096. 4. Lu H, Galeano MCR, Ott E, Kaeslin G, Kausalya PJ, Kramer C, et al. Mutations in DZIP1L, which encodes a ciliary-transition-zone protein, cause autosomal recessive polycystic kidney disease. Nat Genet. 2017;49(7):1025–34. https://doi.org/10.1038/ng.3871. 5. Sweeney WE, Avner ED, et al. Polycystic Kidney Disease, Autosomal Recessive. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. Gene Reviews. Seattle: University of Washington; 2001.
|
|